XYLASOL 20MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
XYLASOL 20MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
XYLASOL 20MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Xylazine hydrochloride
Target species:
-
Dog
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Xylazine hydrochloride20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Dog
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- aniMedica GmbH
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 92271/27-12-2012/K-0157501
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
